Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join


Jun 11, 2024 9:30 AM - Jun 11, 2024 12:30 PM

Real-World Evidence: The Evolving Landscape of Regulators, Data, and Integrated Use

This is a virtual pre-meeting Short Course in conjunction with the DIA Global Annual Meeting.


Pre-registration required and is an additional fee.

*Please note: Short Courses are stand-alone events. Registration for the main conference, forum, etc. are not mandatory.

Already registered? Log in to DIA's My Account My Events.

This Short Course will be offered virtually – Join from anywhere! This short course will provide an overview of how real-world evidence (RWE) is being used today for evidence generation in major markets. The primary focus is evidence generation for regulatory use and how RWD/E is used earlier in clinical development. Following the major points from recently released guidance documents from around the world, we will explain how the fitness of evidence from real-world data are assessed for any use case, key elements of design and analysis, and the current status when real-world studies will be sufficient to meet regulatory evidence requirements.

Register for two or more Short Courses and receive $50 off each Short Course! Purchases must be made at the same time to receive the discount. Discounts will be reflected on the last page of the cart.

Registered attendees for this virtual Short Course will receive access to the course recording for 2 full months post-course! This allows you to remain flexible with your schedule and not worry if you need to step out momentarily. Have a conflict with the dates of the course, but are interested in the content? Register anyway and you will receive access to the recording!

Who should attend?

Professionals involved in or interested in learning about real-world evidence, real-world data, epidemiology, clinical research, regulatory and technology development.

Learning objectives

At the conclusion of this short course, participants should be able to:
  • Discuss how regulators are using RWE for regulatory decision support
  • Recognize how RWD/E is being used earlier in clinical development
  • Describe the concept of RWD being “fit for purpose” including the importance of relevant data and methodologic rigor
  • Identify how RWE can be assembled and integrated to generate a compelling message

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.